Partners

Founded by brigham and women's hospital and massachusetts general hospital

Office of Continuing Professional Development

Topics in Gastrointestinal Cancer 2018

Description

DFABWMGH_1.10.14.jpg

Saturday, February 3, 2018
8:00 p.m. - 2:00 p.m.

Four Seasons Hotel
200 Boylston Street
Boston, MA 02116

Thank you for your interest in this CME program. Online registration has now closed. If you're still interested in attending, we are accepting on-site registrations on Saturday morning, February 3rd, beginning at 8:00 a.m.

Course Overview

Novel treatments for gastrointestinal cancers have resulted in considerable improvements in patient outcomes, but have also increased complexity of treatment decisions. This annual symposium will share up-to-date information on the treatment and prevention of gastrointestinal cancers. It is designed to help participants incorporate complex treatment approaches into their daily practice. Through lecture and case-based presentations, specialists in the field will discuss:

- Management and treatment options for colon, rectal, and pancreatic cancers, and neuroendocrine tumors
- New surgical approaches for esophageal cancer
- The role of genetic evaluations in gastrointestinal malignancies
- Novel approaches for radiation therapy in gastrointestinal cancers, and
- The evolving role of targeted therapies for colorectal cancer

Learning Objectives

Upon completion of this course, participants will be able to:

1. Evaluate new surgical approaches for esophageal cancers and apply these procedures into routine clinical practice
2. Recognize appropriate management and treatment options for colon, rectum, and pancreatic cancers as well as neuroendocrine tumors, and, where appropriate, utilize these approaches in routine clinical practice
3. Identify targeted therapies that inform treatment for colorectal cancer, and understand the rationale for these approaches
4. Evaluate the role of genetics in gastrointestinal malignancies
5. Recognize appropriate use of radiation therapy in gastrointestinal cancers, and, where appropriate, utilize these approaches in routine clinical practice

Target Audience

This educational activity is designed for oncologists (medical, radiation, surgical), gastroenterologists, surgeons, primary care physicians, nurse practitioners, and other interested clinicians.

Agenda

8:00 a.m.

Registration Check-in and Continental Breakfast

8:15 a.m.

Welcome and Introduction
Brian M. Wolpin, MD, MPH

8:20 a.m.

Use of Targeted Therapies in the Treatment of Colorectal Cancer
Ryan Corcoran, MD, PhD

8:50 a.m.

Latest Advances in Adjuvant Therapy for Colon Cancer: Duration of Therapy and Adjunctive Therapies
Jeffrey A. Meyerhardt, MD, MPH

9:20 a.m.

Genetic Evaluation for Patients with Gastrointestinal Malignancies
Kimberly Perez, MD

9:50 a.m.

New Treatment Strategies in pancretaic and Biliary Cancer
Brian M. Wolpin, MD, MPH

10:20 a.m.

Break

10:45 a.m.

Surgical Management of Esophageal Cancer
Scott J. Swanson, MD

11:15 a.m.

Evolving Role of Radiation Therapy in Gastrointestinal Cancers
Theodore S. Hong, MD

11:45 a.m.

Advances in the Management of Neuroendocrine Tumors
Matthew H. Kulke, MD

12:15 p.m.

Case Presentations from the Audience*

Moderator: Brian M. Wolpin, MD, MPH
Panelists: All presenters

*Participants will be encouraged to present their own problem cases for discussion by the panel, and are encouraged to bring case materials, including scans and other diagnostic information.

12:55 p.m.

Concluding Remarks
Brian M. Wolpin, MD, MPH

1:00 p.m.

Lunch

2:00 p.m.

Meeting Adjourn

Please note: Program changes/substitutions may be made without notice.

Faculty

Brian M. Wolpin, MD, MPH
Course Director and Program Moderator
Director, Gastrointestinal Cancer Center,
Robert T. and Judith B. Hale Chair in Pancreatic Cancer,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Ryan Corcoran, MD, PhD
Director, Gastrointestinal Cancer Center Program;
Massachusetts General Hospital Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Theodore S. Hong, MD
Director, Gastrointestinal Service, Department of Radiation Oncology;
Associate Clinical Director, Department of Radiation Oncology,
Massachusetts General Hospital Cancer Center;
Associate Professor of Radiation Oncology, Harvard Medical School

Matthew H. Kulke, MD
Director, Program in Neuroendocrine and Carcinoid Tumors,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine, Harvard Medical School

Jeffrey A. Meyerhardt, MD, MPH
Clinical Director, Gastrointestinal Cancer Center
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine, Harvard Medical School

Kimberly Perez, MD
Medical Oncologist, Gastrointestinal Cancer Center and
Center for Cancer Genetics and Prevention,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine, Harvard Medical School

Scott J. Swanson, MD
Chief Surgical Officer,
Dana-Farber Cancer Institute;
Vice Chair for Clinical Cancer, Department of Surgery,
Brigham and Women's Hospital;
Professor of Surgery, Harvard Medical School

Registration Information

$50.00 through January 21, 2018
$60.00 after January 21, 2018

Registration fee is non-refundable; includes course materials, continental breakfast, and lunch.

Forms of payment accepted:
- Credit card: Online
- Check: Mail/On-site
*Please note: cash is not accepted

Course Location and Directions

This course will be held at the Four Seasons Hotel, 200 Boylston Street, Boston MA 02116.

For directions, click here (URL link: http://www.fourseasons.com/boston/destination/directions_and_maps/)

Contact

For questions regarding the conference, please call 800-553-3787.

For questions regarding registration, please contact Partners Office of Continuing Professional Development atpartnerscpd@partners.org or 857-282-2513.

If you have any food allergies, or if you require accommodations such as an ASL interpreter, materials in an alternative format, or wheelchair access, please contact our course coordinator before the event at kwooten@partners.org; 800-553-3787.

Provided By

Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital Cancer Center, and Partners HealthCare System

DFABWMGH_1.10.14.jpg


Partners_FoundedBy.jpg

Additional Information

About the Gastrointestinal Cancer Centers of
Dana-Farber/Brigham and Women's Cancer Center and
Massachusetts General Hospital Cancer Center

We offer comprehensive care for patients with gastrointestinal cancers, including cancers of the colon, rectum, stomach, esophagus, pancreas, anus, bile duct (cholangiocarcinoma), liver, gallbladder, and small bowel, as well as carcinoid and islet cell malignancies. At each cancer center, care is provided by a multidisciplinary team that includes medical oncologists; radiation oncologists; colorectal, gastrointestinal, and oncologic surgeons; and gastroenterologists, with consultative support from gastrointestinal pathologists and gastrointestinal diagnostic and interventional radiologists.

These Harvard Medical School-affiliated centers provide the latest therapies in surgery, chemotherapy, and radiation for gastrointestinal cancers. Both centers also have active clinical research programs exploring new drug treatments and multimodality therapies. Genetic counseling, molecular diagnostic testing, and support services, including social work, nutrition counseling, and educational and support groups are also offered.

CME Information

PHYSICIAN
Acccreditation
Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of4.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING
Credit Designation Statement
4.3 nursing contact hours will be awarded for attending the presentation in its entirety and completing an evaluation.

Approval Statement
Dana-Farber Cancer Institute is an approved provider of continuing nursing education by the American Nurses Association Massachusetts, and accredited approver by the American Nurses' Credentialing Center's Commission on Accreditation.